Ziegler Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Ziegler Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,637	Closed	-$1.04M	–	396
2023 Q1	$1.04M	Buy	27,637 +270	+1%	+$8.85K	0.04%	283
2022 Q4	$767K	Sell	27,367 -6,380	-19%	-$185K	0.03%	316
2022 Q3	$948K	Sell	33,747 -199	-0.6%	-$6.5K	0.04%	301
2022 Q2	$1.18M	Buy	33,946 +767	+2%	+$27.4K	0.05%	277
2022 Q1	$1.19M	Sell	33,179 -2,700	-8%	-$76.6K	0.05%	278
2021 Q4	$836K	Sell	35,879 -11,604	-24%	-$237K	0.03%	339
2021 Q3	$903K	Buy	47,483 +13,736	+41%	+$269K	0.03%	340
2021 Q2	$680K	Buy	+33,747	New	+$636K	0.02%	370

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ziegler Capital Management's AMPH Position: Q2 2023 in Review

Ziegler Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2023, closing a stake of 27,637 shares — an estimated $1.04M sold.

Ziegler Capital Management first reported a position in AMPH in Q2 2021 and held it in 8 quarters. The position peaked at $1.19M in Q1 2022. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

Ziegler Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Ziegler Capital Management sold 27,637 Amphastar Pharmaceuticals shares in Q2 2023, an estimated $1.04M.
Ziegler Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 8 quarters.
Ziegler Capital Management's Amphastar Pharmaceuticals position peaked at $1.19M in Q1 2022.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on Ziegler Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.